Hope Health Center (HHC)
is an independent private oncology clinic. At HHC all patients with cancer are treated by “Precision Oncology”. By this method the treatment protocols are customized to the individual patient. Precision oncology is in its infancy period in US and may take another 10-15 years to be used widely as a standard oncology practice. At HHC this has begun already with years of experience to treat the most advanced cancers. At initial assessment we perform a comprehensive genetic study on tumor sample using “the next generation gene sequencing” method which is the most advanced tool in this field. We try to find the driver genes responsible for tumor growth in that sample. At the same time tumor is tested with different chemotherapies to find the most sensitive one and avoiding the ones without efficacy. We also test the tumor for its sensitivity to different immunotherapies including ant-PD1 or anti-PDL1. Based on all these test results a special customized therapy will be designed which may include not only the most effective chemotherapies but also immunotherapy, targeted therapy and biologic therapies.
- Appointment Flexibility
- We Work Through Your Case With You
- Caring, Dedicated Service
- Work Directly With Our Doctor
Who We Are
Hope Health Center
At HHC patients who failed standard therapies and were sent to hospice by academic centers have shown responses up to 80-100% to personalized therapies and been enjoying extended life with good quality. By precision individualized cancer therapy it doesn’t matter where the original tumor is located. We study the tumor behavior and its nature and try to match the best treatment for it with maximum response and least toxicity. For instance at HHC we treated an advanced metastatic pancreatic cancer patient who had failed standard chemo with a new customized combination of chemo and a targeted therapy used for lymphoma resulting in about 90% response and almost normal quality of life. Patient’s tumors in his liver disappeared completely. You cant see such a response with standard chemo alone. Patient had also no significant side effects with therapy. In academic centers , national cancer centers and all community practices patients with advanced cancers are offered two options. If suitable patient is enrolled in a clinical trial testing a new medication which may or may not work with unknown toxicities. If the individual patient is not a candidate for trials then he/she is offered a standard protocol which uses the same chemo for all patients without knowing the efficacy or potential toxicity for each individual. After using all limited lines of chemo patients are sent to palliative care/hospice with progressive/terminal disease. Read more
Meet Dr. Nader Javadi
Dr. Nader Javadi M.D.
Hematology / Oncology
Medical Dir. of Hope Health Center
Asst. clinical Prof. at UCI school of medicine.
Dr. Nader Javadi, M.D. is a board certified Hematologist and Oncologist with more than 15 years of experience. He’s a graduate of Internal medicine residency at Cleveland Clinic and completed his fellowship in Hematology/Oncology program at St. Louis University hospital. He’s the founder and current director of Hope Health Center at Reseda, California. Dr. Javadi has been a Clinical Assistant professor at University of California – Irvine between 2004-2007. During the last 15 years he has been involved in many clinical trials in the field of oncology and been a thought leader in specific areas like prostate, liver, ovarian, colon and lung cancers. He has been the chairman of the cancer committee at Riverside Cancer Foundation between 2004-2007 (Riverside, California). Dr. Javadi has been featured as an oncology expert in many national and international TV and radio stations including NBC news and multiple Persian and Armenian TV/radio stations.